FeNO non-suppression identifies corticosteroid-resistant type-2 signaling in severe asthma

Detalles Bibliográficos
Main Authors:	Couillard, S, Shrimanker, R, Chaudhuri, R, Mansur, AH, McGarvey, LP, Heaney, LG, Fowler, SJ, Bradding, P, Pavord, ID, Hinks, TSC
Formato:	Conference item
Idioma:	English
Publicado:	BMJ Publishing Group 2021

FeNO non-suppression identifies corticosteroid-resistant type-2 signaling in severe asthma por Couillard, S, Shrimanker, R, Chaudhuri, R, Mansur, A, McGarvey, L, Heaney, L, Fowler, S, Bradding, P, Pavord, I, Hinks, T

Publicado 2021

Journal article